Palvella Therapeutics, Inc. (PVLA) Shares Outstanding (Weighted Average) (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Shares Outstanding (Weighted Average) for 12 consecutive years, with $1.8 million as the latest value for Q3 2024.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 43.22% to $1.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $1.8 million, a 43.22% increase, with the full-year FY2023 number at $90.1 million, up 21.43% from a year prior.
- Shares Outstanding (Weighted Average) was $1.8 million for Q3 2024 at Palvella Therapeutics, roughly flat from $1.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $90.1 million in Q4 2023 to a low of $931000.0 in Q1 2023.
- A 5-year average of $45.2 million and a median of $55.2 million in 2020 define the central range for Shares Outstanding (Weighted Average).
- Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 98.74% in 2023, then soared 90.14% in 2024.
- Palvella Therapeutics' Shares Outstanding (Weighted Average) stood at $54.5 million in 2020, then increased by 18.48% to $64.5 million in 2021, then increased by 14.91% to $74.2 million in 2022, then rose by 21.43% to $90.1 million in 2023, then tumbled by 98.03% to $1.8 million in 2024.
- Per Business Quant, the three most recent readings for PVLA's Shares Outstanding (Weighted Average) are $1.8 million (Q3 2024), $1.8 million (Q2 2024), and $1.8 million (Q1 2024).